Latest SEC Filings — Page 35
Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.
CHTR filing
Reliance Reports Strong Q1 with 15.5% Revenue Growth and 36.4% EPS Increase, Raises Dividend
MVB Financial Reports Strong Q1 Earnings, Announces $10M Fintech Investment Gain for Q2
Banco Santander Announces Key Leadership for Combined US Operations Post-Webster Acquisition
Seagate Reports Strong Q3 Results with Significant Revenue & Cash Flow Growth, Substantial Debt Reduction, and Increased Dividend
John B. Sanfilippo & Son Reports Mixed Q3 Results, Declares Special Dividend Amid Operational Expansion
ICRL filing
CWT filing
NewcelX Discloses Going Concern Warning Amidst Rising Losses and Highly Dilutive Financing
Element Solutions Reports Mixed Q1: Strong Sales Growth Driven by Acquisitions, But GAAP Net Income and EPS Decline Amid Increased Debt
Allstate Reports Massive Q1 2026 Earnings Surge Driven by Lower Catastrophe Losses and Strong Underwriting
HCI Group Files Definitive Proxy for Annual Meeting, Discloses Significant Executive Compensation and Strong 2025 Performance
SF filing
Acadia Realty Trust Reports Strong Q1 Net Income, Strategic Dispositions, and Major Debt Refinancing
PENN Entertainment Reports Strong Q1 Operational Performance and Cash Flow, Interactive Segment Losses Narrow Significantly
Antero Midstream Reports Strong Q1 2026 Results with Operational Growth and M&A Integration Details
Vista Energy Reports Near-Doubled Q1 Revenue, Strong Profit Growth, and Details on Major Acquisition
TRV filing
Verano Holdings Details Annual Meeting Proposals, Highlights Positive Cannabis Rescheduling Impact
GAB filing
Redwood Trust Reports Q1 2026 Earnings with Record Mortgage Banking Volume and Dividend Coverage
CalEthos Secures Critical $16M Loan and Warrants to Fund Data Center Development
KORE filing
NPO filing
INVO Fertility Receives Nasdaq Delisting Warning for Late 10-K Filing
VICI filing
Crescent Biopharma Reports Q1 2026 Results, Extends Cash Runway to 2028, and Details Clinical Pipeline Progress
PAVmed Finalizes Registration for Resale of Over 9.2 Million Shares by Investors, Creating Significant Market Overhang
PGAC filing
Moelis & Co Reports Q1 EPS Miss, Announces $117M Share Repurchases and $0.65 Dividend